Amgen’s Blincyto gains EU approval for consolidation phase treatment in B-ALL#Blincyto #LeukemiaTreatment #CancerResearch #BiTEtherapy #Amgen #OncologyNews
#Blincyto #LeukemiaTreatment #CancerResearch #BiTEtherapy #Amgen #OncologyNews